title: Distinct internalization pathways of human amylin monomers and its cytotoxic oligomers in pancreatic cells.
abstract: Toxic human amylin oligomers and aggregates are implicated in the pathogenesis of type 2 diabetes mellitus (TTDM). Although recent studies have shown that pancreatic cells can recycle amylin monomers and toxic oligomers, the exact uptake mechanism and trafficking routes of these molecular forms and their significance for amylin toxicity are yet to be determined. Using pancreatic rat insulinoma (RIN-m5F) beta (β)-cells and human islets as model systems we show that monomers and oligomers cross the plasma membrane (PM) through both endocytotic and non-endocytotic (translocation) mechanisms, the predominance of which is dependent on amylin concentrations and incubation times. At low (≤ 100 nM) concentrations, internalization of amylin monomers in pancreatic cells is completely blocked by the selective amylin-receptor (AM-R) antagonist, AC-187, indicating an AM-R dependent mechanism. In contrast at cytotoxic (µM) concentrations monomers initially (1 hour) enter pancreatic cells by two distinct mechanisms: translocation and macropinocytosis. However, during the late stage (24 hours) monomers internalize by a clathrin-dependent but AM-R and macropinocytotic independent pathway. Like monomers a small fraction of the oligomers initially enter cells by a non-endocytotic mechanism. In contrast a majority of the oligomers at both early (1 hour) and late times (24 hours) traffic with a fluid-phase marker, dextran, to the same endocytotic compartments, the uptake of which is blocked by potent macropinocytotic inhibitors. This led to a significant increase in extra-cellular PM accumulation, in turn potentiating amylin toxicity in pancreatic cells. Our studies suggest that macropinocytosis is a major but not the only clearance mechanism for both amylin's molecular forms, thereby serving a cyto-protective role in these cells.
authors.affiliation: Department of Biological Sciences, The George Washington University, Washington, District of Columbia, United States of America.
authors.forename: Saurabh
authors.initials: S
authors.lastname: Trikha
authors.forename: Aleksandar M
authors.initials: AM
authors.lastname: Jeremic
mesh_terms: D000818:Animals; D001704:Biopolymers / Q000378:metabolism; D045744:Cell Line, Tumor; D002478:Cells, Cultured; D004705:Endocytosis; D006801:Humans; D058228:Islet Amyloid Polypeptide / Q000378:metabolism*; D018613:Microscopy, Confocal; D010179:Pancreas / Q000166:cytology / Q000378:metabolism*; D051381:Rats; D058287:Receptors, Islet Amyloid Polypeptide / Q000378:metabolism
chemical_list: D001704:Biopolymers; D058228:Islet Amyloid Polypeptide; D058287:Receptors, Islet Amyloid Polypeptide
references.citation: Nat Rev Mol Cell Biol. 2007 Aug;8(8):603-12
references.pmid: 17609668
references.citation: Diabetes. 2003 Nov;52(11):2759-66
references.pmid: 14578294
references.citation: Biochem J. 2003 Sep 15;374(Pt 3):779-84
references.pmid: 12812521
references.citation: Endocr Rev. 2008 May;29(3):303-16
references.pmid: 18314421
references.citation: Methods Cell Biol. 2008;90:267-86
references.pmid: 19195555
references.citation: Horm Metab Res. 1993 Mar;25(3):135-7
references.pmid: 8477949
references.citation: J Mol Biol. 2004 Sep 17;342(3):877-87
references.pmid: 15342243
references.citation: Diabetes. 1999 Mar;48(3):491-8
references.pmid: 10078548
references.citation: J Mol Biol. 2009 Oct 30;393(3):765-75
references.pmid: 19720065
references.citation: Mol Neurodegener. 2010 May 17;5:19
references.pmid: 20478062
references.citation: Regul Pept. 1993 Jan 22;43(1-2):91-6
references.pmid: 8426912
references.citation: Nat Cell Biol. 2009 May;11(5):510-20
references.pmid: 19404330
references.citation: Diabetologia. 1999 Oct;42(10):1219-27
references.pmid: 10525663
references.citation: Biochem Biophys Res Commun. 2000 Jan 19;267(2):619-25
references.pmid: 10631112
references.citation: PLoS Pathog. 2010 Apr 22;6(4):e1000866
references.pmid: 20421949
references.citation: J Cell Biol. 1993 Dec;123(5):1107-17
references.pmid: 8245121
references.citation: J Cell Biol. 1998 Feb 9;140(3):553-63
references.pmid: 9456316
references.citation: Diabetologia. 2004 Feb;47(2):157-69
references.pmid: 14722650
references.citation: Nature. 1998 May 28;393(6683):333-9
references.pmid: 9620797
references.citation: Experientia. 1996 Jul 15;52(7):677-9
references.pmid: 8698109
references.citation: Mol Biol Cell. 2000 Oct;11(10):3453-67
references.pmid: 11029048
references.citation: PLoS One. 2009;4(2):e4627
references.pmid: 19247480
references.citation: FEBS Lett. 2004 Nov 5;577(1-2):117-20
references.pmid: 15527771
references.citation: Diabetes. 2007 Feb;56(2):304-10
references.pmid: 17259373
references.citation: Biochem Biophys Res Commun. 1991 Aug 30;179(1):1-9
references.pmid: 1679326
references.citation: Biochem Biophys Res Commun. 1989 Apr 28;160(2):961-7
references.pmid: 2655598
references.citation: Diabetes. 2004 Jun;53(6):1509-16
references.pmid: 15161755
references.citation: Cesk Fysiol. 2002 Dec;51(4):176-80
references.pmid: 12608111
references.citation: Exp Diabetes Res. 2008;2008:421287
references.pmid: 18483616
references.citation: Biochim Biophys Acta. 2009 Jun;1790(6):566-74
references.pmid: 19264107
references.citation: FEBS J. 2006 Aug;273(15):3614-24
references.pmid: 16884500
references.citation: J Neurosci. 2009 Apr 1;29(13):4252-62
references.pmid: 19339619
references.citation: Diabetes Res Clin Pract. 1992 Jan;15(1):77-84
references.pmid: 1311671
references.citation: Nature. 1994 Apr 21;368(6473):756-60
references.pmid: 8152488
references.citation: J Biol Chem. 2005 Jan 21;280(3):2352-60
references.pmid: 15533943
references.citation: Endocrinology. 2008 Nov;149(11):5423-31
references.pmid: 18599553
references.citation: Pharmacol Rev. 2002 Jun;54(2):233-46
references.pmid: 12037140
references.citation: J Mol Biol. 2002 Nov 22;324(2):271-85
references.pmid: 12441106
references.citation: Biochem J. 2004 Jan 1;377(Pt 1):1-16
references.pmid: 14505490
references.citation: Diabetes. 2007 Sep;56(9):2284-94
references.pmid: 17563070
references.citation: FASEB J. 2012 Mar;26(3):1228-38
references.pmid: 22183778
references.citation: BMC Cell Biol. 2005 Aug 11;6:30
references.pmid: 16095541
references.citation: PLoS One. 2010 Jun 29;5(6):e11360
references.pmid: 20613878
references.citation: Am J Physiol Endocrinol Metab. 2006 Dec;291(6):E1317-24
references.pmid: 16849627
references.citation: J Pharmacol Exp Ther. 2000 Jul;294(1):61-72
references.pmid: 10871296
references.citation: Mol Biol Cell. 2001 Sep;12(9):2578-89
references.pmid: 11553700
references.citation: Pharmacol Rev. 2006 Mar;58(1):32-45
references.pmid: 16507881
references.citation: J Biol Chem. 2011 Oct 14;286(41):36086-36097
references.pmid: 21865171
references.citation: Diabetologia. 2008 Dec;51(12):2252-62
references.pmid: 18751967
references.citation: Br J Pharmacol. 2012 May;166(1):151-67
references.pmid: 22014233
references.citation: Mol Pharmacol. 2005 May;67(5):1655-65
references.pmid: 15692146
references.citation: Biochemistry. 2007 Jul 31;46(30):8850-60
references.pmid: 17595112
references.citation: Diabetologia. 2009 Apr;52(4):626-35
references.pmid: 19148619
references.citation: Proc Natl Acad Sci U S A. 1996 Jul 9;93(14):7283-8
references.pmid: 8692984
references.citation: Mol Biol Cell. 2006 Dec;17(12):5381-9
references.pmid: 17050736
references.citation: Apoptosis. 2012 Jan;17(1):37-47
references.pmid: 21947943
references.citation: Int J Alzheimers Dis. 2010 Dec 20;2011:548380
references.pmid: 21197446
references.citation: Am J Physiol Regul Integr Comp Physiol. 2004 Sep;287(3):R568-74
references.pmid: 15130879
references.citation: Am J Pathol. 2011 Jan;178(1):140-9
references.pmid: 21224052
references.citation: J Neurosci. 2008 Mar 12;28(11):2874-82
references.pmid: 18337418
references.citation: J Cell Biol. 1996 Dec;135(5):1249-60
references.pmid: 8947549
references.citation: Biochemistry. 2008 Dec 2;47(48):12680-8
references.pmid: 18989933
references.citation: J Neurosci. 2004 Jun 16;24(24):5579-84
references.pmid: 15201330
references.citation: J Mol Biol. 2008 Feb 8;376(1):42-54
references.pmid: 18155730
references.citation: Mol Neurodegener. 2012 Aug 14;7:38
references.pmid: 22892036
references.citation: Diabetes Metab. 2008 Feb;34 Suppl 2:S43-8
references.pmid: 18640585
references.citation: Diabetes. 2007 Aug;56(8):2016-27
references.pmid: 17475933
references.citation: J Biol Chem. 2009 Dec 4;284(49):33957-65
references.pmid: 19833724
references.citation: Mol Pharmacol. 1999 Jul;56(1):235-42
references.pmid: 10385705
references.citation: Proc Natl Acad Sci U S A. 2008 Apr 22;105(16):6033-8
references.pmid: 18408164
references.citation: Proc Natl Acad Sci U S A. 2005 Jul 26;102(30):10427-32
references.pmid: 16020533
references.citation: Cell Biol Int. 2001;25(4):339-50
references.pmid: 11319840
references.citation: Diabetes. 2003 Sep;52(9):2315-20
references.pmid: 12941771
references.citation: Mol Pharmacol. 2004 Jan;65(1):207-13
references.pmid: 14722252
references.citation: J Biol Chem. 1996 Jan 26;271(4):1988-92
references.pmid: 8567648
references.citation: Proc Natl Acad Sci U S A. 2011 Oct 11;108(41):16883-8
references.pmid: 21969533
references.citation: Diabetes. 2007 Jan;56(1):65-71
references.pmid: 17192466
references.citation: J Biophys. 2011;2011:414729
references.pmid: 21687343
references.citation: Phys Chem Chem Phys. 2013 Aug 14;15(30):12558-71
references.pmid: 23793354